The LORAZEPAM TABLETS is a the manufacturer industrial component. Key specifications include administration: ORAL, special_features: CONTROLLED SUBSTANCE CLASSIFICATION:SCHEDULE IV;, features_provided: INDIVIDUALLY SEALED, primary_container_type: CARD, medical_designation_and_grade: UNITED STATES PHARMACOPEIA, total_primary_container_quantity: 10. This product is currently in active production with full OEM support.
This part is cataloged in the Federal Logistics Information System (FLIS) under NSN 6505-01-280-9924, indicating validated use in U.S. government and defense logistics supply chains. Available through authorized enterprise resellers and TPM (Third Party Maintenance) channels.
Verify compatibility with your specific system configuration before ordering.
| administration | ORAL |
| special_features | CONTROLLED SUBSTANCE CLASSIFICATION:SCHEDULE IV; |
| features_provided | INDIVIDUALLY SEALED |
| primary_container_type | CARD |
| medical_designation_and_grade | UNITED STATES PHARMACOPEIA |
| total_primary_container_quantity | 10 |
| primary_container_content_quantity | 10.000 TABLETS |
| active_medicament_medicinal_strength | 0.500 MILLIGRAMS LORAZEPAM ACTIVE INGREDIENT |
| NSN | 6505-01-280-9924 |
| PRIMARY CONTAINER TYPE | CARD |
| PRIMARY CONTAINER CONTENT QUANTITY | 10.000 TABLETS |
| MEDICAL DESIGNATION AND GRADE | UNITED STATES PHARMACOPEIA |
| SPECIAL FEATURES | CONTROLLED SUBSTANCE CLASSIFICATION:SCHEDULE IV; |
| ADMINISTRATION | ORAL |
| ACTIVE MEDICAMENT MEDICINAL STRENGTH | 0.500 MILLIGRAMS LORAZEPAM ACTIVE INGREDIENT |
| TOTAL PRIMARY CONTAINER QUANTITY | 10 |
| FEATURES PROVIDED | INDIVIDUALLY SEALED |